$ROL
ROLLINS INC

2024 Q2 Form 10-Q Financial Statement

#000008483924000070 Filed on April 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $891.9M $748.3M $754.1M
YoY Change 8.67% 13.73% 14.02%
Cost Of Revenue $410.3M $365.6M $370.3M
YoY Change 6.79% 11.85% 12.87%
Gross Profit $481.6M $382.8M $383.8M
YoY Change 10.33% 15.59% 15.14%
Gross Profit Margin 54.0% 51.15% 50.89%
Selling, General & Admin $271.5M $223.1M $218.6M
YoY Change 6.35% 13.55% 14.82%
% of Gross Profit 56.38% 58.27% 56.95%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $27.71M $27.31M $26.14M
YoY Change 4.81% 21.37% 46.28%
% of Gross Profit 5.75% 7.13% 6.81%
Operating Expenses $271.5M $250.4M $244.7M
YoY Change -3.63% 27.46% 17.52%
Operating Profit $182.4M $132.4M $139.1M
YoY Change 17.82% 17.98% 11.19%
Interest Expense -$7.775M -$7.725M -$8.258M
YoY Change 62.49% 1561.29% 2300.58%
% of Operating Profit -4.26% -5.83% -5.94%
Other Income/Expense, Net $412.0K -$61.00K $15.86M
YoY Change -59.57% -101.29% 429.2%
Pretax Income $175.0M $124.6M $146.7M
YoY Change 15.89% 7.0% 14.83%
Income Tax $45.60M $30.24M $37.87M
% Of Pretax Income 26.06% 24.27% 25.82%
Net Earnings $129.4M $94.39M $108.8M
YoY Change 17.48% 6.98% 23.31%
Net Earnings / Revenue 14.51% 12.61% 14.43%
Basic Earnings Per Share $0.27 $0.19
Diluted Earnings Per Share $0.27 $0.19 $0.22
COMMON SHARES
Basic Shares Outstanding 484.2M shares 483.9M shares 484.0M shares
Diluted Shares Outstanding 484.4M shares 484.3M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $106.7M $113.0M $103.8M
YoY Change -31.05% 0.42% 8.89%
Cash & Equivalents $106.7M $113.0M $103.8M
Short-Term Investments
Other Short-Term Assets $84.53M $62.71M $54.19M
YoY Change 35.27% 76.76% 58.68%
Inventory $37.93M $35.70M $33.38M
Prepaid Expenses
Receivables $205.2M $177.3M $178.2M
Other Receivables $39.96M $35.72M $37.03M
Total Short-Term Assets $474.3M $424.4M $406.6M
YoY Change 2.22% 15.36% 16.64%
LONG-TERM ASSETS
Property, Plant & Equipment $129.1M $468.8M $126.7M
YoY Change -68.2% 277.67% -1.08%
Goodwill $1.116B $1.095B $1.070B
YoY Change 6.71% 28.42% 26.41%
Intangibles $546.0M $549.4M $545.7M
YoY Change -3.14% 32.3% 30.33%
Long-Term Investments
YoY Change
Other Assets $44.39M $41.94M $46.82M
YoY Change -5.49% 1.42% 19.94%
Total Long-Term Assets $2.292B $2.234B $2.189B
YoY Change 7.35% 26.16% 23.42%
TOTAL ASSETS
Total Short-Term Assets $474.3M $424.4M $406.6M
Total Long-Term Assets $2.292B $2.234B $2.189B
Total Assets $2.767B $2.659B $2.595B
YoY Change 6.43% 24.3% 22.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $54.08M $40.04M $49.20M
YoY Change -27.32% 2.47% 14.96%
Accrued Expenses $262.8M $228.4M $253.4M
YoY Change 18.0% 18.63% 13.45%
Deferred Revenue $196.7M $186.0M $172.4M
YoY Change 7.33% 11.01% 9.04%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $610.0M $591.9M $576.7M
YoY Change 5.95% 26.66% 16.79%
LONG-TERM LIABILITIES
Long-Term Debt $502.0M $510.9M $490.8M
YoY Change 48.75% 718.34% 1130.08%
Other Long-Term Liabilities $418.5M $388.3M $372.4M
YoY Change 21.68% 20.83% 15.97%
Total Long-Term Liabilities $920.5M $899.2M $863.2M
YoY Change 35.09% 134.3% 139.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $610.0M $591.9M $576.7M
Total Long-Term Liabilities $920.5M $899.2M $863.2M
Total Liabilities $1.530B $1.491B $1.440B
YoY Change 21.74% 75.19% 68.44%
SHAREHOLDERS EQUITY
Retained Earnings $645.0M $588.2M $566.4M
YoY Change -14.84% -17.3% -17.56%
Common Stock $484.3M $484.2M $484.1M
YoY Change -1.73% -1.74% -1.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.236B $1.167B $1.156B
YoY Change
Total Liabilities & Shareholders Equity $2.767B $2.659B $2.595B
YoY Change 6.43% 24.3% 22.31%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $129.4M $94.39M $108.8M
YoY Change 17.48% 6.98% 23.31%
Depreciation, Depletion And Amortization $27.71M $27.31M $26.14M
YoY Change 4.81% 21.37% 46.28%
Cash From Operating Activities $145.1M $127.4M $152.8M
YoY Change -1.56% 26.46% 23.85%
INVESTING ACTIVITIES
Capital Expenditures $8.696M $7.171M $11.19M
YoY Change 28.35% -6.09% 45.14%
Acquisitions $47.13M
YoY Change 204.47%
Other Investing Activities -$32.46M -$45.29M $625.0K
YoY Change -89.57% 6977.19% -120.45%
Cash From Investing Activities -$41.16M -$52.47M -$10.56M
YoY Change -87.06% 286.06% -1.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities -109.6M -64.25M -183.2M
YoY Change -151.89% -9.61% 31.08%
NET CHANGE
Cash From Operating Activities 145.1M 127.4M 152.8M
Cash From Investing Activities -41.16M -52.47M -10.56M
Cash From Financing Activities -109.6M -64.25M -183.2M
Net Change In Cash -5.673M 10.71M -40.90M
YoY Change -113.95% -37.55% 50.91%
FREE CASH FLOW
Cash From Operating Activities $145.1M $127.4M $152.8M
Capital Expenditures $8.696M $7.171M $11.19M
Free Cash Flow $136.4M $120.3M $141.6M
YoY Change -3.0% 29.12% 22.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
94394000 usd
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
365558000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
326842000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
223057000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
196431000 usd
CY2024Q1 us-gaap Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
27310000 usd
CY2023Q1 us-gaap Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
22502000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
615925000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
545775000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
132424000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
112240000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7725000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-465000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-61000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4714000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
124638000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
116489000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30244000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28255000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
94394000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
88234000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
484131000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
492516000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
484318000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
492701000 shares
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.13
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
94394000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
88234000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-5774000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
97000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
57000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
162000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5717000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
259000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
88677000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
88493000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1155567000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-5774000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
57000 usd
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
72589000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7181000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
11340000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1167496000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1267197000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
88234000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
97000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
162000 usd
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
64053000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5947000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
9832000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1287752000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
94394000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
88234000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
27310000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
22502000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7181000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5947000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7693000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3896000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
368000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
4714000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
6929000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6400000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1533000 usd
CY2024Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1822000 usd
CY2023Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
4421000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2286000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1043000 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
8867000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1501000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9396000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-17548000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
13691000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8656000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-6303000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
7697000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
127433000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
100773000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
47132000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
15480000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7171000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7636000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
712000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
8886000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1126000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-640000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-52465000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13590000 usd
CY2024Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1474000 usd
CY2023Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
4098000 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
110000000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
180000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
55000000 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
90000000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
115000000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
72589000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
64053000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11340000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11443000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1149000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1488000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-64254000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-71082000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1568000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1056000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9146000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17157000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103825000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95346000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112971000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112503000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
8707000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
429000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5591000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12572000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
45531000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
20828000 usd
CY2024Q1 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
12 business
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
305000000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
748349000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
658015000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
748349000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
658015000 usd
CY2024Q1 rol Total Revenue Recognized From Both The Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothTheBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
61900000 usd
CY2023Q1 rol Total Revenue Recognized From Both The Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothTheBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
55500000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
210059000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
187994000 usd
CY2024Q1 rol Contract With Customer Liability Increase From Cash Receipts
ContractWithCustomerLiabilityIncreaseFromCashReceipts
74796000 usd
CY2023Q1 rol Contract With Customer Liability Increase From Cash Receipts
ContractWithCustomerLiabilityIncreaseFromCashReceipts
65626000 usd
CY2024Q1 rol Total Revenue Recognized From Both The Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothTheBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
61888000 usd
CY2023Q1 rol Total Revenue Recognized From Both The Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothTheBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
55466000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
222967000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
198154000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
36900000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
37700000 usd
CY2024Q1 rol Long Term Unearned Revenue Recognition Period Or Less
LongTermUnearnedRevenueRecognitionPeriodOrLess
P5Y
CY2024Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
18400000 usd
CY2024Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
3800000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
0 usd
CY2022 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
0 usd
CY2024Q1 rol Financing Receivable Percentage Of Finance Subject To Credit Score
FinancingReceivablePercentageOfFinanceSubjectToCreditScore
1
CY2023Q4 rol Accounts And Financing Receivable After Allowance For Credit Loss Current And Non Current
AccountsAndFinancingReceivableAfterAllowanceForCreditLossCurrentAndNonCurrent
21399000 usd
CY2024Q1 rol Accounts And Financing Receivables Credit Loss Expense Reversal
AccountsAndFinancingReceivablesCreditLossExpenseReversal
7693000 usd
CY2024Q1 rol Accounts And Financing Receivable Allowance For Credit Loss Write Off
AccountsAndFinancingReceivableAllowanceForCreditLossWriteOff
9546000 usd
CY2024Q1 rol Accounts And Financing Receivable Allowance For Credit Loss Recovery
AccountsAndFinancingReceivableAllowanceForCreditLossRecovery
1575000 usd
CY2024Q1 rol Accounts And Financing Receivable After Allowance For Credit Loss Current And Non Current
AccountsAndFinancingReceivableAfterAllowanceForCreditLossCurrentAndNonCurrent
21121000 usd
CY2022Q4 rol Accounts And Financing Receivable After Allowance For Credit Loss Current And Non Current
AccountsAndFinancingReceivableAfterAllowanceForCreditLossCurrentAndNonCurrent
19041000 usd
CY2023Q1 rol Accounts And Financing Receivables Credit Loss Expense Reversal
AccountsAndFinancingReceivablesCreditLossExpenseReversal
3896000 usd
CY2023Q1 rol Accounts And Financing Receivable Allowance For Credit Loss Write Off
AccountsAndFinancingReceivableAllowanceForCreditLossWriteOff
6614000 usd
CY2023Q1 rol Accounts And Financing Receivable Allowance For Credit Loss Recovery
AccountsAndFinancingReceivableAllowanceForCreditLossRecovery
1629000 usd
CY2023Q1 rol Accounts And Financing Receivable After Allowance For Credit Loss Current And Non Current
AccountsAndFinancingReceivableAfterAllowanceForCreditLossCurrentAndNonCurrent
17952000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1070310000 usd
CY2024Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
27337000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
2506000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
1095141000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
692810000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
285379000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
407431000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
672252000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
268480000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
403772000 usd
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
141959000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
141962000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
549390000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
545734000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18700000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
61384000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
72147000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
68042000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
64176000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
62165000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
72600000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
64100000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.13
CY2024Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
11300000 usd
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
9800000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
484131000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
492516000 shares
CY2024Q1 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
187000 usd
CY2023Q1 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
185000 usd
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
484318000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
492701000 shares
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30200000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28300000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000084839-24-000070-index-headers.html Edgar Link pending
0000084839-24-000070-index.html Edgar Link pending
0000084839-24-000070.txt Edgar Link pending
0000084839-24-000070-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rol-20240331.htm Edgar Link pending
rol-20240331.xsd Edgar Link pending
rol-20240331xexx311.htm Edgar Link pending
rol-20240331xexx312.htm Edgar Link pending
rol-20240331xexx321.htm Edgar Link pending
rol-20240331_g1.jpg Edgar Link pending
rol-20240331_g2.jpg Edgar Link pending
rol-20240331_g3.jpg Edgar Link pending
rol-20240331_g4.jpg Edgar Link pending
Show.js Edgar Link pending
rol-20240331_def.xml Edgar Link unprocessable
rol-20240331_lab.xml Edgar Link unprocessable
rol-20240331_pre.xml Edgar Link unprocessable
rol-20240331_htm.xml Edgar Link completed
rol-20240331_cal.xml Edgar Link unprocessable